ARTELO BIOSCIENCES, INC.

ARTL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014
Operating Activities
Net Income $-234.9K $-29.7K $-15.2K $-15.3K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation $3.3K
Net Cash from Operating Activities $-216.8K $-18.5K $-13.5K $-15.3K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $785.3K
Net Change in Cash $568.5K $-13.4K $2.3K $14.7K
Free Cash Flow
← Newer Page 2 of 2 Older →